Rottendorf Pharma's Bold Step in Pharmaceutical Validation
In a significant move for the pharmaceutical manufacturing sector, Rottendorf Pharma has teamed up with ValGenesis, Inc. to adopt the ValGenesis Validation Lifecycle Management System (VLMS). This collaboration is not just a strategic choice; it highlights the growing importance of digital transformation in the industry today.
Rottendorf Pharma: A Brief Introduction
With over 95 years of experience, Rottendorf Pharma is a major player in the development and manufacturing of oral solid dosage forms. Operating as a Contract Development and Manufacturing Organization (CDMO), the company serves pharmaceutical and biotechnology firms around the globe. Their foundation-owned structure emphasizes their commitment to long-term partnerships that create real value for their customers.
Why Choose ValGenesis VLMS?
The decision to adopt ValGenesis VLMS stemmed from its ability to standardize and streamline validation processes at Rottendorf Pharma. The features of VLMS 5.0, particularly its intuitive interface, have been highly praised as they facilitate efficient management of validation tasks. Additionally, ValGenesis's responsiveness and cost-effectiveness played a pivotal role in Rottendorf Pharma's choice of this advanced digital solution.
Key Advantages of VLMS
ValGenesis VLMS brings several benefits that are especially beneficial for Rottendorf Pharma. Its streamlined processes are designed to cut down the time and resources needed for validation tasks. Importantly, the strong technology along with a clear roadmap for enhancements means that Rottendorf Pharma can expect ongoing value from this platform as it continues to develop.
A Partnership Looking Forward
Steve Reynolds, Chief Revenue Officer at ValGenesis, highlights the significant impact of this partnership on the pharmaceutical supply chain in Germany. He mentions, "Rottendorf Pharma's choice of our digital validation platform reflects ValGenesis' commitment to improving the quality and efficiency of drug delivery processes. This partnership is poised to enhance their manufacturing capabilities and aligns perfectly with their strategic goals."
Thoughts from Rottendorf Pharma
Markus Krellmann, Head of Validation at Rottendorf Pharma, discussed the reasons behind their decision. He expressed assurance that ValGenesis VLMS delivers the necessary tools to digitize and optimize their operations, noting that the software's cutting-edge technology and future innovation plans ensure lasting value for their organization.
About Rottendorf Pharma
Rottendorf Pharma takes a specialized approach to contract manufacturing, focusing on a comprehensive suite of services centered around oral solid dosage forms. They implement three key service concepts: Total Process Ownership (TPO©), Total Technological Mastering (TTM), and Total Supply Integrity (TSI). This framework underlines their dedication to a customer-focused strategy that consistently yields exceptional results.
About ValGenesis
ValGenesis, Inc. is well-known for creating an innovative software platform designed to manage compliance-based validation activities for life science companies. As a leader in offering enterprise applications that oversee the corporate validation lifecycle, ValGenesis ensures full compliance with U.S. regulatory standards. Their effort in developing cutting-edge solutions has earned them industry recognition, including the prestigious New Innovative Technology Award from the Parenteral Drug Association.
Frequently Asked Questions
1. What is ValGenesis VLMS?
ValGenesis VLMS is a digital validation lifecycle management system aimed at automating and streamlining validation processes in life science companies.
2. Why did Rottendorf Pharma choose ValGenesis?
Rottendorf Pharma opted for ValGenesis VLMS because of its capability to standardize processes, its user-friendly design, cost-effectiveness, and the ongoing support provided by the ValGenesis team.
3. What sectors does Rottendorf Pharma serve?
Rottendorf Pharma operates within the pharmaceutical and biotechnology sectors globally, with a specific focus on oral solid dosage forms as a CDMO.
4. What are the core principles of Rottendorf Pharma?
Rottendorf Pharma's core principles are Total Process Ownership (TPO©), Total Technological Mastering (TTM), and Total Supply Integrity (TSI), which shape their operational approaches.
5. How has ValGenesis been recognized in the industry?
ValGenesis received the New Innovative Technology Award from the Parenteral Drug Association for its groundbreaking digital validation solutions.
